Kestra Medical plans insider stock sale in 2026

Kestra Medical Technologies, Ltd. reported a planned sale of 5,391 shares of common stock through Merrill Lynch on the NASDAQ on 08/03/2026, with an indicated value of $128,312.27.

Rhea-AI Filing Summary

Kestra Medical Technologies, Ltd. reported a planned sale of 5,391 shares of common stock through Merrill Lynch on the NASDAQ on 08/03/2026, with an indicated value of $128,312.27. The shares relate to performance share unit awards that vested on 07/17/2026 under the issuer’s equity compensation plan. In the prior three months, Vaseem Mahboob sold 3,980 shares for $90,560.62 on 07/30/2026 and 8,817 shares for $199,344.62 on 07/31/2026.

Key Figures

Planned shares to be sold: 5,391 shares Planned sale value: $128,312.27 Vesting date of performance share units: 07/17/2026 +4 more

7 metrics

Planned shares to be sold 5,391 shares Common stock sale planned for 08/03/2026 through Merrill Lynch on NASDAQ

Planned sale value $128,312.27 Indicated value for 5,391 common shares to be sold on 08/03/2026

Vesting date of performance share units 07/17/2026 Vesting date for awards underlying the 5,391 shares to be sold

Shares sold 07/30/2026 3,980 shares Common stock sold by Vaseem Mahboob on 07/30/2026

Proceeds 07/30/2026 $90,560.62 Value of KMTS common stock sold on 07/30/2026

Shares sold 07/31/2026 8,817 shares Common stock sold by Vaseem Mahboob on 07/31/2026

Proceeds 07/31/2026 $199,344.62 Value of KMTS common stock sold on 07/31/2026

Key Terms

performance share unit awards, equity compensation plan, securities sold during the past 3 months

3 terms

performance share unit awards financial

"Vesting of performance share unit awards"

equity compensation plan financial

"Granted as part of issuer equity compensation plan"

A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.

securities sold during the past 3 months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is Kestra Medical Technologies (KMTS) planning under this filing?

Kestra Medical Technologies is planning a sale of 5,391 shares of common stock on 08/03/2026 through Merrill Lynch on the NASDAQ, with an indicated value of $128,312.27 tied to vested performance share unit awards.

What is the source of the KMTS shares to be sold on 08/03/2026?

The 5,391 shares of KMTS common stock to be sold on 08/03/2026 arise from the vesting of performance share unit awards on 07/17/2026, granted as part of the issuer’s equity compensation plan.

Which broker and market are involved in the planned KMTS share sale?

The planned KMTS sale of 5,391 common shares with value $128,312.27 is to be executed through Merrill Lynch, located at 225 Liberty Street, New York, on the NASDAQ market on 08/03/2026.

What recent KMTS stock sales by Vaseem Mahboob are disclosed?

Vaseem Mahboob sold 3,980 KMTS common shares for $90,560.62 on 07/30/2026 and 8,817 shares for $199,344.62 on 07/31/2026, as part of securities sold during the past three months.

How many total KMTS shares did Vaseem Mahboob sell over the two disclosed days?

Over the two disclosed days, Vaseem Mahboob sold 3,980 shares on 07/30/2026 and 8,817 shares on 07/31/2026. Each transaction is separately reported with proceeds of $90,560.62 and $199,344.62, respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 04:43 PM Accepted by SEC EDGAR 08/03/2026 - 04:42 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001655157
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KESTRA MEDICAL TECHNOLOGIES, LTD.
SEC File Number	001-42549
Address of Issuer	3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WASHINGTON 98033
Phone	(425) 279-8002
Name of Person for Whose Account the Securities are To Be Sold	Mahboob Vaseem
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	5391	128312.27	58602497	08/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/17/2026	Vesting of performance share unit awards	KESTRA MEDICAL TECHNOLOGIES, LTD.			5391	07/17/2026	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Vaseem Mahboob 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	07/30/2026	3980	90560.62
Vaseem Mahboob 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	07/31/2026	8817	199344.62

144: Remarks and Signature

Remarks
Date of Notice	08/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Vaseem Mahboob
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)